Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Approaching erectile dysfunction in dermatology patients.

Ladizinski B, Federman DG.

JAMA Dermatol. 2013 Jul;149(7):783-4. doi: 10.1001/jamadermatol.2013.289. No abstract available.

PMID:
23864079
2.

Treatments for erectile dysfunction in spinal cord lesioned patients. Are there alternatives to phosphodiesterase type 5 inhibitors?

Wyndaele JJ.

Spinal Cord. 2015 Dec;53(12):841. doi: 10.1038/sc.2015.209. No abstract available.

PMID:
26634316
3.

Efficacy and safety of phosphodieterase-5 inhibitors for the treatment of erectile dysfunction secondary to spinal cord injury.

Wyndaele JJ.

Spinal Cord. 2016 Jul;54(7):493. doi: 10.1038/sc.2016.98. No abstract available.

PMID:
27345458
4.

A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases.

Chung E, Broc GB.

Expert Opin Pharmacother. 2011 Jun;12(8):1341-1348. doi: 10.1517/14656566.2011.584064. Review. No abstract available.

PMID:
21548725
5.

Dermatologic diseases and their effects on male sexual functions.

Ermertcan AT, Temeltaş G.

J Dtsch Dermatol Ges. 2010 Aug;8(8):592-7. doi: 10.1111/j.1610-0387.2010.07436.x. Epub 2010 Apr 26. Review.

PMID:
20438601
6.

ED drugs after cancer treatment don't protect erectile function.

[No authors listed]

Harv Mens Health Watch. 2014 Jul;18(12):8. No abstract available.

PMID:
25219008
7.

[Therapy of erectile dysfunction after radical prostatectomy].

Radnaev LG, Govorov AV, Pushkar' DIu.

Urologiia. 2010 Jul-Aug;(4):75-9. Review. Russian. No abstract available.

PMID:
20967987
8.

Efficacy and safety of phosphodiesterase-5 inhibitors for treating erectile dysfunction in kidney transplant recipients: a meta-analysis.

Fanbin L, Mei Y, Yan Z, Yirong Y, Shaoling Z, Yong C, Peng X.

Exp Clin Transplant. 2014 Jun;12(3):184-9. Review.

9.

[Correction of erectile dysfunction in patients undergoing radical prostatectomy].

Iudovskiĭ SO, Pushkar' DIu.

Urologiia. 2014 Mar-Apr;(2):66, 68-71. Russian.

PMID:
24956677
10.

Erectile dysfunction.

Muneer A, Kalsi J, Nazareth I, Arya M.

BMJ. 2014 Jan 27;348:g129. doi: 10.1136/bmj.g129. Review. No abstract available.

PMID:
24468580
11.

[Treatment of erectile dysfunction].

Schubert-Zsilavecz M.

Pharm Unserer Zeit. 2010 Sep;39(5):385-90. doi: 10.1002/pauz.201000384. Review. German. No abstract available.

PMID:
20818688
12.

Erectile dysfunction.

Shamloul R, Ghanem H.

Lancet. 2013 Jan 12;381(9861):153-65. doi: 10.1016/S0140-6736(12)60520-0. Epub 2012 Oct 5. Review.

PMID:
23040455
13.

Newer phosphodiesterase inhibitors: comparison with established agents.

McNamara ER, Donatucci CF.

Urol Clin North Am. 2011 May;38(2):155-63. doi: 10.1016/j.ucl.2011.03.005. Review.

PMID:
21621082
14.

[Erectile dysfunction. Another option].

Sabourin G.

Perspect Infirm. 2011 Nov-Dec;8(6):56. French. No abstract available.

PMID:
22097429
15.

PDE-5 inhibitors: clinical points.

Doumas M, Lazaridis A, Katsiki N, Athyros V.

Curr Drug Targets. 2015;16(5):420-6. Review.

PMID:
25392015
16.

[Levitra (oral dispersible tablet)--an innovative drug for the treatment of patients with erectile dysfunction].

Korneev IA.

Urologiia. 2013 Mar-Apr;(2):106-8, 110-1. Review. Russian.

PMID:
23789375
17.

Taking the stress out of treating erectile dysfunction.

Muller AJ, Regier L, Jensen B.

Can Fam Physician. 2010 Sep;56(9):898-903. No abstract available.

18.

Delayed penile rehabilitation post radical prostatectomy.

Chung E, Brock GB.

J Sex Med. 2010 Oct;7(10):3233-6; quiz 3237-8. No abstract available.

PMID:
21053404
19.

Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.

Kaiho Y, Yamashita S, Arai Y.

Int J Urol. 2013 Mar;20(3):285-9. doi: 10.1111/iju.12071. Epub 2013 Jan 14. Review.

20.

Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction.

Dorsey P, Keel C, Klavens M, Hellstrom WJ.

Expert Opin Pharmacother. 2010 May;11(7):1109-22. doi: 10.1517/14656561003698131. Review.

PMID:
20402554

Supplemental Content

Support Center